Selected article for: "action management and acute sars respiratory syndrome coronavirus"

Author: Fadaka, Adewale Oluwaseun; Sibuyi, Nicole Remaliah Samantha; Adewale, Olusola Bolaji; Bakare, Olalekan Olanrewaju; Akanbi, Musa Oyebowale; Klein, Ashwil; Madiehe, Abram Madimabe; Meyer, Mervin
Title: Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2
  • Cord-id: wrui3i2l
  • Document date: 2020_8_26
  • ID: wrui3i2l
    Snippet: The emergence of coronavirus disease 2019 (COVID-19) in December 2019 has resulted in over 20 million cases and 741,808 deaths globally, affecting more than 200 countries. COVID-19 was declared a pandemic on 11 March 2020 by the World Health Organization. The disease is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). There is limited information on COVID-19, and treatment has so far focused on supportive care and use of repurposed drugs. COVID-19 can be transmitted via pe
    Document: The emergence of coronavirus disease 2019 (COVID-19) in December 2019 has resulted in over 20 million cases and 741,808 deaths globally, affecting more than 200 countries. COVID-19 was declared a pandemic on 11 March 2020 by the World Health Organization. The disease is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). There is limited information on COVID-19, and treatment has so far focused on supportive care and use of repurposed drugs. COVID-19 can be transmitted via person-to-person contact through droplet spread. Some of the recommended precautionary measures to reduce the rate of disease spread include social distancing, good hygiene practices, and avoidance of crowded areas. These measures are effective because the droplets are heavy and can only travel approximately 1 meter in the air, settling quickly on fixed surfaces. Promising strategies to combat SARS-CoV-2 include discovery of therapeutic targets/drugs and vaccines. In this review, we summarize the epidemiology, pathophysiology, and diagnosis of COVID-19. We also address the mechanisms of action of approved repurposed drugs for therapeutic management of the disease.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • abdominal pain and acute inflammatory: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abdominal pain and acute pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • abdominal pain vomiting and acute ards respiratory distress syndrome: 1
    • abdominal pain vomiting and acute inflammatory: 1, 2, 3, 4
    • abdominal pain vomiting and acute pneumonia: 1, 2, 3, 4, 5, 6
    • abdominal pain vomiting diarrhea and acute inflammatory: 1, 2, 3
    • abdominal pain vomiting diarrhea and acute pneumonia: 1, 2
    • abdominal pain vomiting diarrhea fever and acute inflammatory: 1
    • accessory protein and activity expression: 1, 2
    • accessory protein and acute ards respiratory distress syndrome: 1
    • accessory protein and acute pneumonia: 1
    • accurate calculation and acute pneumonia: 1
    • accurate consistent and active area: 1
    • accurate prediction and active area: 1
    • accurate prediction and acute ards respiratory distress syndrome: 1, 2
    • accurate prediction and acute inflammatory: 1
    • accurate prediction and acute pneumonia: 1, 2, 3, 4
    • ace inhibitor and activity expression: 1, 2, 3, 4